nodes	percent_of_prediction	percent_of_DWPC	metapath
Dipyridamole—ADA—C-MYB transcription factor network—CD34—vascular cancer	0.0534	0.0534	CbGpPWpGaD
Dipyridamole—PDE3B—PKB-mediated events—TSC2—vascular cancer	0.0472	0.0472	CbGpPWpGaD
Dipyridamole—PDE3B—PI3K Cascade—TSC2—vascular cancer	0.0232	0.0232	CbGpPWpGaD
Dipyridamole—PDE1C—Downstream signaling of activated FGFR—TSC2—vascular cancer	0.0199	0.0199	CbGpPWpGaD
Dipyridamole—PDE3B—IRS-mediated signalling—TSC2—vascular cancer	0.0194	0.0194	CbGpPWpGaD
Dipyridamole—PDE6B—Disease—WWTR1—vascular cancer	0.019	0.019	CbGpPWpGaD
Dipyridamole—PDE6A—Disease—WWTR1—vascular cancer	0.019	0.019	CbGpPWpGaD
Dipyridamole—PDE3B—IRS-related events—TSC2—vascular cancer	0.0189	0.0189	CbGpPWpGaD
Dipyridamole—PDE1C—Downstream signal transduction—TSC2—vascular cancer	0.0187	0.0187	CbGpPWpGaD
Dipyridamole—PDE3B—IRS-related events triggered by IGF1R—TSC2—vascular cancer	0.0187	0.0187	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling by FGFR—TSC2—vascular cancer	0.0186	0.0186	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling by ERBB2—TSC2—vascular cancer	0.0186	0.0186	CbGpPWpGaD
Dipyridamole—PDE1C—DAP12 signaling—TSC2—vascular cancer	0.0185	0.0185	CbGpPWpGaD
Dipyridamole—PDE3B—Insulin receptor signalling cascade—TSC2—vascular cancer	0.0182	0.0182	CbGpPWpGaD
Dipyridamole—PDE3B—IGF1R signaling cascade—TSC2—vascular cancer	0.0182	0.0182	CbGpPWpGaD
Dipyridamole—PDE1C—DAP12 interactions—TSC2—vascular cancer	0.0174	0.0174	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling by FGFR in disease—TSC2—vascular cancer	0.0174	0.0174	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling by EGFR—TSC2—vascular cancer	0.0172	0.0172	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling by EGFR in Cancer—TSC2—vascular cancer	0.0171	0.0171	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling by PDGF—TSC2—vascular cancer	0.017	0.017	CbGpPWpGaD
Dipyridamole—PDE1C—NGF signalling via TRKA from the plasma membrane—TSC2—vascular cancer	0.0154	0.0154	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by Insulin receptor—TSC2—vascular cancer	0.0152	0.0152	CbGpPWpGaD
Dipyridamole—PDE6A—Signaling Pathways—WWTR1—vascular cancer	0.0133	0.0133	CbGpPWpGaD
Dipyridamole—PDE6B—Signaling Pathways—WWTR1—vascular cancer	0.0133	0.0133	CbGpPWpGaD
Dipyridamole—PDE1C—Disease—WWTR1—vascular cancer	0.0124	0.0124	CbGpPWpGaD
Dipyridamole—PDE6G—Disease—WWTR1—vascular cancer	0.0122	0.0122	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling by NGF—TSC2—vascular cancer	0.0118	0.0118	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—WWTR1—vascular cancer	0.0113	0.0113	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—WWTR1—vascular cancer	0.0113	0.0113	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—WWTR1—vascular cancer	0.011	0.011	CbGpPWpGaD
Dipyridamole—PDE1A—Downstream signaling of activated FGFR—TSC2—vascular cancer	0.0106	0.0106	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—WWTR1—vascular cancer	0.0101	0.0101	CbGpPWpGaD
Dipyridamole—PDE1A—Downstream signal transduction—TSC2—vascular cancer	0.00998	0.00998	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by FGFR—TSC2—vascular cancer	0.00993	0.00993	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by ERBB2—TSC2—vascular cancer	0.00989	0.00989	CbGpPWpGaD
Dipyridamole—PDE1A—DAP12 signaling—TSC2—vascular cancer	0.00984	0.00984	CbGpPWpGaD
Dipyridamole—PDE1B—Downstream signaling of activated FGFR—TSC2—vascular cancer	0.00972	0.00972	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—WWTR1—vascular cancer	0.00937	0.00937	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—WWTR1—vascular cancer	0.00937	0.00937	CbGpPWpGaD
Dipyridamole—PDE1A—DAP12 interactions—TSC2—vascular cancer	0.00926	0.00926	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by FGFR in disease—TSC2—vascular cancer	0.00926	0.00926	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by EGFR—TSC2—vascular cancer	0.00917	0.00917	CbGpPWpGaD
Dipyridamole—PDE1B—Downstream signal transduction—TSC2—vascular cancer	0.00913	0.00913	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by EGFR in Cancer—TSC2—vascular cancer	0.00909	0.00909	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by FGFR—TSC2—vascular cancer	0.00909	0.00909	CbGpPWpGaD
Dipyridamole—PDE1C—Immune System—CD34—vascular cancer	0.00908	0.00908	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by PDGF—TSC2—vascular cancer	0.00905	0.00905	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by ERBB2—TSC2—vascular cancer	0.00904	0.00904	CbGpPWpGaD
Dipyridamole—PDE1B—DAP12 signaling—TSC2—vascular cancer	0.009	0.009	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—WWTR1—vascular cancer	0.00869	0.00869	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—WWTR1—vascular cancer	0.00857	0.00857	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by FGFR in disease—TSC2—vascular cancer	0.00846	0.00846	CbGpPWpGaD
Dipyridamole—PDE1B—DAP12 interactions—TSC2—vascular cancer	0.00846	0.00846	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by EGFR—TSC2—vascular cancer	0.00839	0.00839	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—WWTR1—vascular cancer	0.00835	0.00835	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by EGFR in Cancer—TSC2—vascular cancer	0.00831	0.00831	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by PDGF—TSC2—vascular cancer	0.00828	0.00828	CbGpPWpGaD
Dipyridamole—PDE1A—NGF signalling via TRKA from the plasma membrane—TSC2—vascular cancer	0.0082	0.0082	CbGpPWpGaD
Dipyridamole—ADA—Metabolism—WWTR1—vascular cancer	0.00762	0.00762	CbGpPWpGaD
Dipyridamole—PDE1B—NGF signalling via TRKA from the plasma membrane—TSC2—vascular cancer	0.0075	0.0075	CbGpPWpGaD
Dipyridamole—PDE1C—Innate Immune System—TSC2—vascular cancer	0.00675	0.00675	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—WWTR1—vascular cancer	0.00661	0.00661	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—WWTR1—vascular cancer	0.00661	0.00661	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by NGF—TSC2—vascular cancer	0.0063	0.0063	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—WWTR1—vascular cancer	0.00605	0.00605	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by NGF—TSC2—vascular cancer	0.00577	0.00577	CbGpPWpGaD
Dipyridamole—PDE6B—Disease—TSC2—vascular cancer	0.00556	0.00556	CbGpPWpGaD
Dipyridamole—PDE6A—Disease—TSC2—vascular cancer	0.00556	0.00556	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—WWTR1—vascular cancer	0.00554	0.00554	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—WWTR1—vascular cancer	0.00541	0.00541	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—WWTR1—vascular cancer	0.00506	0.00506	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—WWTR1—vascular cancer	0.00492	0.00492	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—CD34—vascular cancer	0.00484	0.00484	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—WWTR1—vascular cancer	0.00463	0.00463	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—CD34—vascular cancer	0.00442	0.00442	CbGpPWpGaD
Dipyridamole—ADA—Metabolism—HBA1—vascular cancer	0.00426	0.00426	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—WWTR1—vascular cancer	0.00423	0.00423	CbGpPWpGaD
Dipyridamole—PDE1C—Immune System—TSC2—vascular cancer	0.00393	0.00393	CbGpPWpGaD
Dipyridamole—PDE6B—Signaling Pathways—TSC2—vascular cancer	0.00389	0.00389	CbGpPWpGaD
Dipyridamole—PDE6A—Signaling Pathways—TSC2—vascular cancer	0.00389	0.00389	CbGpPWpGaD
Dipyridamole—PDE1C—Disease—TSC2—vascular cancer	0.00363	0.00363	CbGpPWpGaD
Dipyridamole—PDE1A—Innate Immune System—TSC2—vascular cancer	0.0036	0.0036	CbGpPWpGaD
Dipyridamole—PDE6G—Disease—TSC2—vascular cancer	0.00358	0.00358	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—TSC2—vascular cancer	0.00331	0.00331	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—TSC2—vascular cancer	0.00331	0.00331	CbGpPWpGaD
Dipyridamole—PDE1B—Innate Immune System—TSC2—vascular cancer	0.00329	0.00329	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—TSC2—vascular cancer	0.00322	0.00322	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—HBA1—vascular cancer	0.0031	0.0031	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—TSC2—vascular cancer	0.00295	0.00295	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—TSC2—vascular cancer	0.00274	0.00274	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—TSC2—vascular cancer	0.00274	0.00274	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—TSC2—vascular cancer	0.00254	0.00254	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—TSC2—vascular cancer	0.00251	0.00251	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—TSC2—vascular cancer	0.00244	0.00244	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—TSC2—vascular cancer	0.00209	0.00209	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—TSC2—vascular cancer	0.00193	0.00193	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—TSC2—vascular cancer	0.00193	0.00193	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—TSC2—vascular cancer	0.00192	0.00192	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—TSC2—vascular cancer	0.00177	0.00177	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—TSC2—vascular cancer	0.00158	0.00158	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—WWTR1—vascular cancer	0.00152	0.00152	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—TSC2—vascular cancer	0.00148	0.00148	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—TSC2—vascular cancer	0.00144	0.00144	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—TSC2—vascular cancer	0.00135	0.00135	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—TSC2—vascular cancer	0.00124	0.00124	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—HBA1—vascular cancer	0.000851	0.000851	CbGpPWpGaD
